NCT05141383View on ClinicalTrials.gov

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)

NACompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

May 4, 2022

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions

Prostate CancerHealthy Donors

Interventions

OTHER

Urine sampling

A blood sample and a urine sample after prostate massage will be carried out at baseline

Trial Locations (1)

75005

Institut Curie, Paris

All Listed Sponsors

lead

Institut Curie

OTHER